Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)

Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)

Noha Rashad,1 Omar Abdel-Rahman2 1Medical Oncology Department, Maadi Armed Forces Hospital, 2Clinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt Abstract: Rolapitant is a highly selective neurokinin-1 receptor antagonist, orally administered for a single dose of 1...

Full description

Bibliographic Details
Main Authors: Rashad N, Abdel-Rahman O
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Drug Design, Development and Therapy
Subjects:
Nausea
vomiting
chemotherapy
rolapitant
CINV
Online Access:https://www.dovepress.com/differential-clinical-pharmacology-of-rolapitant-in-delayed-chemothera-peer-reviewed-article-DDDT

Similar Items

Similar Items